Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
Syncona brings together leading experts in Treg Research for the formation of Quell Therapeutics
Today Syncona announced the foundation of Quell Therapeutics (Quell), a new cell therapy company, with a £35 million commitment in a Series A financing of which £1 million will be invested in syndicate by UCL Technology Fund. Funds will be tranched in three phases with Syncona acquiring a 69.3 per cent stake in the business upon third tranche completion.
Novel method of analysis of stroke data
How does Portico Ventures support non-patentable and fast-to-deploy technologies?
As Portico Ventures is well under way at UCL, we catch up with Programme Manager Denisa Naidin on how UCLB’s work is helping to speed up the route to commercialisation for Computer Science innovations at UCL.
SnakeGrid
SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.
Latest news and highlights
Bringing innovation to life
